These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8690755)

  • 21. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry.
    Queiroz C; Barral-Netto M; Bacchi CE
    Acta Cytol; 2001; 45(1):18-22. PubMed ID: 11213499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.
    Schofield K; D'Aquila T; Rimm DL
    Cancer; 1997 Oct; 81(5):293-8. PubMed ID: 9349517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
    Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
    Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
    Marsan C; Gaulier A; Sabatier P; Garcia R
    Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic role of claudins in serous effusions.
    Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B
    Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
    Rehnberg J; Zendehrokh N; Dejmek A
    Anal Quant Cytol Histol; 2007 Aug; 29(4):217-20. PubMed ID: 17879629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
    Ko EC; Jhala NC; Shultz JJ; Chhieng DC
    Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK; Dey P; Rana P
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma.
    Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J
    Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
    Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
    Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of p53 protein in the study of serous effusions.
    Zoppi JA; Pellicer EM; Sundblad AS
    Acta Cytol; 1995; 39(4):721-4. PubMed ID: 7631546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases.
    Diaz-Arias AA; Loy TS; Bickel JT; Chapman RK
    Diagn Cytopathol; 1993 Oct; 9(5):516-21. PubMed ID: 8287759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
    Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
    J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative INTERSPECIMEN variability during biphasic pleural fluid cytological sampling in adenocarcinoma effusions.
    Michaelides SA; Bablekos GD; Michailidis AS; Analitis A; Kapatsis PX; Ellina E; Maounis N
    Diagn Cytopathol; 2018 Oct; 46(10):840-844. PubMed ID: 30043512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions.
    Ascoli V; Taccogna S; Scalzo CC; Nardi F
    Diagn Cytopathol; 1995 Jun; 12(4):303-8. PubMed ID: 7656755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
    Gupta S; Sodhani P; Jain S
    J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ber-EP4 staining in effusion cytology: A potential source of false positives.
    Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
    Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.